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ABSTRACT 
Introduction: Cervical cancer is a very common female cancer; with up to 524,000 cases being 
diagnosed annually worldwide.1 Human papilloma virus (HPV) has long been established as the 
causative factor in the development of cervical cancer.2, 3 HPV vaccination has been found to 
drastically reduce the development of cervical cancer especially if administered to young people 
before their sexual debut.  This study was to assess the knowledge of primary health care workers 
in the Mamusa and Naledi sub-districts in the North West Province about cervical cancer, HPV 
and the HPV vaccine. 
 
Methods: This was a descriptive cross-sectional study done with 116 primary health care workers 
using a self-administered questionnaire that was derived from a duet of questionnaires previously 
used in Poland and Australia. Adequate knowledge of cervical cancer and HPV vaccination meant 
getting 70% of the questions asked on the subject correctly while a threshold of 80% was used for 
adequate knowledge of HPV vaccination. All categories of primary health workers were included 
in the study asides from pharmacists who were excluded. Descriptive statistics, tests of association 
and logistic regression analysis was used in the study. The survey was done between September to 
November 2016 following ethics approval from the University of Witwatersrand. 
Results: 116 participants were involved in this study. The majority were black female professional 
nurses with diplomas. The mean age of the participants was 36.6 ± 8.7 years. Only 26% of the 
respondents had adequate knowledge of cervical cancer. 41% of respondents had adequate 
knowledge of HPV, while 67% of respondents had adequate knowledge about HPV vaccination. 
In our study, we found a significant association between knowledge of HPV and the health care 
worker category (p < 0.001). There was a significant association between knowledge of HPV 
vaccination and the highest educational level that was attained by the respondents (p= 0.010).  
Conclusion: Primary health care workers form an integral part in the fight against cervical cancer. 
Significant gaps still exist in the level of knowledge of health care workers, particularly in relation 
to cervical cancer and HPV. Improved learning and training opportunities for primary health care 
workers can help correct the knowledge deficit                                                                        
                                                    TABLE OF CONTENTS  
v 
DECLARATION………………………………………………………………………………I 
DEDICATION………………………………………………………………………………...II 
ACKNOWLEDGEMENTS …………………………………………………………………III 
ABSTRACT………………………………………………………………………………….IV 
TABLE OF CONTENT………………………………………………………………………V 
APPENDICES………………………………………………………………………………VII 
LIST OF FIGURES………………………………………………………………………….IX 
LIST OF TABLES …………………………………………………………………………...X 
DEFINITION OF TERMS/ABBREVIATIONS…………………………………………….XI 
CHAPTER ONE INTRODUCTION………………………………………………………1 
1.1 Background to the research………………………………………………………………..1 
1.2 Rationale for the study…………………………………………………………………….3 
CHAPTER TWO LITERATURE REVIEW………………………………………………5 
2.1 Introduction on cervical cancer and HPV…………………………………………………5 
2.2 Risk factors for cervical cancer……………………………………………………………6 
2.3 Demographic characteristics of people having cervical cancer and HPV………………...6 
2.4 Human papilloma virus vaccination……………………………………………………….7 
2.5 Health care workers knowledge of cervical cancer and cervical cancer screening………..8 
2.6 Health care workers knowledge of HPV and HPV vaccination………………………….11 
2.7 Cervical cancer, HPV infection and HIV………………………………………………...14 
CHAPTER THREE   METHODS…………………………………………………………15 
3.1 Aims and objectives……………………………………………………………………...15 
3.1.2 Objectives ……………………………………………………………………………...15 
3.2 Study setting ……………………………………………………………………………..15 
3.3 Study population…………………………………………………………………………16 
vi 
3.4 Sample size……………………………………………………………………………….16 
3.5 Study design……………………………………………………………………………...16 
3.6 Measuring tool……………………………………………………………………………17 
3.7 Data collection……………………………………………………………………………18 
3.8 Data analysis……………………………………………………………………………..19 
3.9 Ethics……………………………………………………………………………………..20 
3.10 Funding……………………………………………………………………………….....20 
CHAPTER FOUR   RESULTS……………………………………………………………21 
4.1 Methodology……………………………………………………………………………..21 
4.2 Demographic of the respondents ………………………………………………………...21 
4.3 Knowledge of primary health care workers about cervical cancer………………………23 
4.3.1 General knowledge of cervical cancer…………………………………………………23 
4.3.2 Relationship between estimated risk factors and occurrence of cervical cancer………24 
4.3.3 Knowledge about primary prevention of cervical cancer……………………………...25 
4.3.4 Knowledge about secondary prevention of cervical cancer……………………………28 
4.4 Knowledge of Human papilloma virus (HPV)…………………………………………...33 
4.5 Knowledge of HPV vaccination…………………………………………………………34 
4.6 Participants knowledge on cervical cancer, HPV and HPV vaccination………………...35 
4.7 Association between knowledge of cervical cancer, HPV, HPV vaccination and socio 
demographic characteristics …………………………………………………………………36 
 
CHAPTER FIVE    DISCUSSION………………………………………………………..46 
5.1 Discussion………………………………………………………………………………..46 
5.2 Socio-demographic characteristics……………………………………………………….46 
5.3 Knowledge of cervical cancer……………………………………………………………47 
vii 
5.4 Knowledge of HPV……………………………………………………………………...50 
5.5 Knowledge of HPV vaccination…………………………………………………………50 
5.6 Conclusion………………………………………………………………………………..52 
CHAPTER SIX RECOMMENDATIONS ………………………………………………..55 
REFERENCES ………………………………………………………………………………56 
 
  
 
 
                                                                  
                                                            
 
                                                           
 
 
 
 
 
 
 
 
                                                
 
                                                            
 
viii 
                                                     APPENDICES  
         
Appendix A   Questionnaire……………………………………………………………………..61 
Appendix B   Participant information sheet……………………………………………………..70 
Appendix C   Clearance certificate………………………………………………………………71  
Appendix D   Clearance from the district ……………………………………………………….72 
Appendix E   Permission to use questionnaire …………………………………………………..73 
Appendix F    Permission to use the CCKP questionnaire ……………………………………...74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                              
                                                               LIST OF FIGURES  
ix 
 
Figure 4.1:  Ideal age reported by participants for HPV vaccination……………………………27 
Figure 4.2:  Time interval for the Pap test……………………………………………………….30 
Figure 4.3:  Age at which women take the Pap test……………………………………………...31 
Figure 4.4:  Participants knowledge of cervical cancer………………………………………….32 
Figure 4.5:   Source of information about cervical cancer ……………………………………....32 
Figure 4.6:  Participants knowledge of cervical cancer, HPV and HPV vaccination……………35 
 
 
 
 
                                   
 
 
 
 
 
   
 
 
 
 
 
                                  
                                                             LIST OF TABLES                             
x 
Table 4.1:  Demographic of Respondents…………………………………………………………………21 
Table 4.2: General knowledge of cervical cancer…………………………………………………………23 
Table 4.3: The relationship between risk factors and occurrence of cervical cancer……………………..24 
Table 4.4:  Knowledge of risk factors for the development of cervical cancer…………………………...25 
Table 4.5: Knowledge of primary prevention of cervical cancer (Vaccines )…………………………….26 
Table 4.6: Knowledge of secondary prevention of cervical cancer reported by participants ……………28 
Table 4.7: Knowledge of Pap smear as reported by participants ………………………………………....29 
Table 4.8: Time at which a woman should undergo pap smear after sexual debut……………………….31 
Table 4.9: Knowledge of HPV…………………………………………………………………………….33 
Table 4.10: Knowledge of HPV vaccination……………………………………………………………...34 
Table 4.11: Correlation of knowledge level of cervical cancer with health care category………………..36 
Table 4.12: Correlation of knowledge level of cervical cancer with highest level of education…………36 
Table 4.13: Correlation of knowledge of cervical cancer and age group…………………………………37 
Table 4.14: Correlation of knowledge of cervical cancer and place of work……………………………..37 
Table 4.15: Correlation of knowledge of HPV with healthcare worker category………………………...38 
Table 4.16: Correlation of knowledge of HPV and highest level of education…………………………..39 
Table 4.17: Correlation of knowledge of HPVand age group…………………………………………….39 
Table 4.18: Correlation of knowledge of HPV vaccination and healthcare worker category…………….40 
Table 4.19:  Correlation of knowledge of HPV vacciantion and place of work…………………………..41 
Table 4.20: Correlation of knowledge of HPV vaccination and highest level of education………………42 
  Table 4.21 :Logistic regression of  socio demographicfactors having significant association with 
knowledge of cervical cancer……………………………………………………………………………...43 
Table 4.22: Logistic regression of socio demographic factors with significant association with knowledge 
of HPV…………………………………………………………………………………………………….44 
Table 4.23:Logistic regression of socio demographic factors with significant association with knowledge 
of HPV vaccination……………………………………………………………………………………......45 
xi 
 
DEFINITION OF TERMS /ABBREVIATIONS  
 
Primary health care workers – includes health worker categories such as doctors, clinical 
associates, professional nurses, enrolled nurses and enrolled nursing assistant in the various 
facilities.  
Adequate knowledge of cervical cancer- ability to get 70% of questions asked regarding cervical 
cancer correctly. 
Adequate knowledge of Human papilloma virus – ability to get 80% of the questions in the HPV 
section correctly. 
Adequate knowledge of HPV vaccination- ability to get 70% of the questions posed correctly in 
the HPV vaccination section. 
HIV – Human Immunodeficiency Virus 
HPV – Human Papilloma Virus 
CCKP 64 – Cervical cancer knowledge prevention questionnaire 
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CHAPTER ONE INTRODUCTION 
 
1.1 Background to the research 
 
Cervical cancer accounts for a significant amount of morbidity and mortality among women 
worldwide, with its attendant sequelae. Global estimates indicate that up to 528,000 new cases of 
cervical cancer are diagnosed annually.1 It comes only after breast, colorectal and lung cancers 
respectively in terms of how commonly it occurs.1 In South Africa, an estimation of its incidence 
indicates that up to 7,735 new diagnoses of cervical cancer are made per annum. It ranks as the 
second leading aetiology of female cancer. In women aged between 15 to 44 years, it has been 
noted to be the most common cancer in South Africa.2  
Annually, 34.8 new cases of cervical cancer are diagnosed per 100 000 women in Sub-Saharan 
Africa, and 22.5 per 100 000 women die from the disease.2 In North America, the estimated figures 
are 6.6 and 2.5 per 100 000 women respectively.2 This huge discrepancy in incidence and mortality 
rates can be attributed to improved efforts in early preventive strategies, improved access to 
cervical screening, and treatment in developed countries as compared to developing countries. 
Other reasons that have been adduced for this difference include superior screening and 
management techniques.2, 3  
The extremely high incidence and mortality figures observed particularly in developing countries 
points to the fact that a lot more still needs to be done to combat the scourge of cervical cancer, 
therefore the fight against cervical cancer must be escalated drastically if the associated mortality 
figures described are to be dealt with appropriately. 
Human papilloma virus (HPV) has been isolated as the causative agent in the development of pre-
invasive and invasive lesions of the cervix, vagina and the anogenital region.4,5,6 While different 
serotypes of the HPV have been isolated, HPV 16 and HPV 18 are implicated in the development 
of malignant disease. Other serotypes that have been implicated in the development of cervical 
cancer include HPV 16, 18, 33, 31 and 45.4,5 Irrefutable evidence of HPV being the causative agent 
in cervical cancer was made in 1976 by Harald Zur Hausen. This was when HPV DNA was 
discovered in cervical cancer and warts.5  
2 
The South African Department of Health, in response to the scourge of cervical cancer, instituted 
the national cervical screening programme to assist in early detection of the disease. The screening 
programme lays out the appropriate algorithm to follow based on the results of the screening tests.6 
According to the national guidelines for cervical cancer screening instituted by the National 
Department of Health in 2005, the Papanicolaou (PAP) smear is the test of choice and it is 
advocated that females should ideally be tested from age 30, 40 and 50. These ten-year intervals 
are chosen based on the fact that the disease has a long premalignant stage, the sensitivity of the 
Pap test, and also due to cost implications.6   
It was envisaged that from the inception of the programme that at least up to 70% of eligible 
women in the population would be reached within 10 years of commencement of the screening 
programme. The objectives of the programme were stated to be the reduction of the incidence of 
carcinoma of the cervix by detection and treatment of the preinvasive stages of the disease, 
reduction of mortality and morbidity associated with the disease, and the reduction of expenditure 
associated with the treatment of invasive stages of the disease.6 
However, it has been noted that due to a myriad of factors, this programme has not been as 
successful as was envisaged at its inception. An underfunded and poorly developed health care 
system might be responsible for this.7 It must also be noted that while the national programme for 
cervical cancer control still promotes the use of the Pap smear as the primary screening test, various 
advances such as the use of HPV testing based on new and relatively cheap technologies have not 
yet been integrated into the national cervical cancer screening guidelines in South Africa.  
In the United States, the recent guidelines for cervical cancer screening recommend no screening 
for women aged below 21. It advocates that women aged 21-29 should be screened with cytology 
alone every three years. It also advocates HPV and cytology co-testing every five years, or 
cytology alone every three years.8  
Recent advances in the fight against cervical cancer in South Africa include the introduction of a 
school-based HPV vaccination to girls of 9 years and above who are in school grade 4.9    It is 
anticipated that eligible girls would be of an age in which they are yet to experience their sexual 
debut. This programme, instituted by the South African Department of Health in conjunction with 
the Department of Education, envisages the administration of two doses of the HPV vaccine to 
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school girls over a six-month period. It is envisaged that it will take up to two decades for the full 
effects of vaccination to result in cervical cancer reduction. 
Health care workers are at the forefront of the fight against cervical cancer. It is therefore essential 
that they are knowledgeable about the risk factors of cervical cancer, HPV vaccination, and the 
human papilloma virus, which has been identified as the principal causal agent of cervical cancer. 
This is essential if the fight against cervical cancer and a drastic reduction in the unacceptably high 
mortality rate, especially in developing countries, is to be achieved.   
 
1.2  Rationale for the study 
  
The management of cervical cancer still presents a huge burden to individuals affected by it and 
their families. A significant proportion of the population depends on the public health system for 
their care with its attendant costs implications. Primary health care workers are an important 
bulwark against the unacceptably high rates of morbidity and mortality of cervical cancer due to 
the important role they play in the education of patients, screening, and the treatment of patients 
in various stages of cervical cancer.  
The community has high expectations of primary health workers in this regard; however we do 
not know exactly if our primary health care workers are sufficiently knowledgeable about cervical 
cancer, HPV and HPV vaccination. 
It must be noted that while a variety of studies have been done worldwide regarding the knowledge 
and awareness of health care workers on cervical cancer, HPV and HPV vaccination, 10, 11 there is 
a paucity of literature pertaining to this subject, especially among rural based South-African 
primary health care workers. This piqued the interest of the researcher to investigate if these 
primary health care workers, who are at the forefront of the fight against cervical cancer, are 
educated about it, and the human papilloma virus and HPV vaccination. 
This study endeavours to ascertain if the different categories of primary health care workers such 
as doctors, professional nurses, enrolled nurses and clinical associates involved in the care of 
women in the Mamusa and Naledi sub-districts, are knowledgeable about cervical cancer, the 
4 
human papilloma virus and HPV vaccination. This would enable us to identify the existing gaps 
in health care worker knowledge, and to take necessary steps to remedy the knowledge deficit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER TWO      LITERATURE REVIEW 
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2.1   Introduction on cervical cancer and HPV 
 
Cervical cancer originates in the cervix, which connects the vagina to the uterus.12 Several authors 
have affirmed that the human papilloma virus (HPV), a sexually transmitted virus,  is the principal 
causative agent of  the  pre-malignant phase of cervical cancer  and  for the future development of  
full-blown cervical cancer itself.4, 12-15  It has been described as a virulent carcinogenic agent  that 
is also involved  in the development of pre-invasive and invasive cancer of the vagina and the 
anogenital region .4, 12, 14, 15 
 
The natural history of HPV has been described by several authors. Almost all HPV infections are 
asymptomatic and are noted to be sexually transmitted. HPV infections usually clear up naturally 
without intervention and in a timely fashion. In patients with intact immunity, the immune system 
negates the subsequent progress of the HPV infection.12, 15   However, in some cases HPV persists, 
resulting in the development of pre-invasive and subsequently invasive forms of cervical cancer. 
HPVs that have been outlined as important in the development of cervical cancer include HPV16 
and 18. Others that have been associated with the development of malignant disease are HPV 31, 
33 and 45 respectively.4, 12, 15 
 
In the development of cervical cancer, there is a progression from persistent HPV infection to the 
discovery of low-grade cervical lesions, which spontaneously resolve in a large proportion of 
patients.4, 11, 12 As opposed to this spontaneous resolution, a minority of women with low-grade 
cervical lesions subsequently progress to high-grade cervical lesions or to pre-cancerous lesions 
involving the glandular cells of the endocervix.12, 15 
 
High-grade cervical lesions are characterized by the presence of pre-cancerous cells on the surface 
of the cervix that are different from normal cells. Lack of proper management results in malignant 
proliferation of these high-grade cervical lesions, with possible invasion of the cervix and 
surrounding organs.12, 15 
 
The development of cervical cancer is an insidious process that can take a long period of time from 
the development of its premalignant stage up to the stage in which cancer becomes full-blown. It 
6 
is a preventable disease, essentially due to this long drawn-out process, hence vaccination, 
elimination of risk factors, screening methods and treatment of the pre-invasive cervical lesions 
are very effective. 4, 12, 15    
 
2.2  Risk factors for cervical cancer  
 
Following the acquisition of HPV, which is primarily the causative agent for the development of 
cervical cancer, certain factors indicate if there would be subsequent progression to pre-invasive 
and invasive cervical lesions. Such factors include multiparity, early primi-gravidity, early sexual 
debut, cigarette smoking, having a high number of sexual partners and having partners who have 
multiple sexual partners. Others include HIV infection or other sexually transmitted infections, 
and immunosuppression due to other diseases.4, 12, 15  
 
Other factors that have been highlighted by researchers as risk factors involved in the development 
of cervical cancer include prolonged use of oral contraceptives ; lack of regular pap tests; previous 
abnormality or cancer of the cervix; poor nutrition; folate deficiency; genetic predisposition; low 
socioeconomic status; multiparity, the use of diethystiboesterol; and age; with cervical cancer more 
preponderant in the elderly than in the younger age group.4,12,15 This can be expected due to the 
insidious nature of the disease. 
 
Other risk factors implicated as possible risk factors in the development of cervical cancer include 
late menopause, herpes, and race, with cervical cancer more common in blacks, Hispanics and 
American Indian women.4, 6, 12, 15 
 
2.3  Demographic characteristics of people having cervical cancer and HPV 
 
In South Africa, about 20 million women are at risk of developing cancer. It is estimated that the 
crude incidence of cervical cancer is about 30.2/100,000.2 With regard to the burden of cervical 
HPV infection among women in South Africa, it is estimated that the prevalence of HPV16 and/ 
7 
or 18 among women with normal cervical cytology is 3.2% while the prevalence of HPV 16/18 
among women with cervical cancer is 64.2%.2 
In 2012, among people aged 15-19, 2 371 new cases of cervical cancer were diagnosed. The 
respective figures for women aged 40-64 and women older than 64 were 4 003 and 1 359 
respectively.2 
In the United States, according to the National Health and Nutritional Examination Survey, it 
was estimated that in 2013-2014, the prevalence of any high-risk genital HPV for adults aged 
18–59 was 45.2% and 25.1% in men, and 39.9% and 20.4% in women. The authors also found 
that prevalence of any and high-risk genital HPV was lower among non-Hispanic Asians and 
higher among non-Hispanic blacks than in both non-Hispanic whites and Hispanic men and 
women.31  
2.4  Human Papilloma Virus vaccination 
 
Advancement in research and medicine have given rise to the development of two types of HPV 
vaccines that are highly effective against the manifestation of cervical cancer.4 This includes the 
bivalent vaccine CervarixTM, that incorporates  virus-like particles (VLP), antigens, for oncogenic 
HPV types 16 and 18; and the quadrivalent vaccine GardasilTM, incorporating  virus-like particles  
(VLP), antigens, for HPV types 16 and 18, and  non oncogenic  HPV types 6 and 11, which are 
the most common aetiological agents for  genital  warts.4 
 
In terms of primary prevention of cervical cancer, the use of prophylactic vaccines is said to be the 
most significant development in the fight against cervical cancer.4, 5 In view of this fact, HPV 
vaccination should be advocated for widespread use in the South African population.4, 5, 14 
 
With regard to the efficacy of the vaccine, the quadrivalent prophylactic vaccine GardasilTM was 
found to be 98.6% effective at 3.6 years against HPV 16 and 18, CIN 2 and 3 lesions, and 
adenocarcinoma.4 It was also noted to have resulted in significant reductions in colposcopy, 
cervical biopsy and definitive therapy in addition to cross protection to other vaccine types.4 With 
regard to the bivalent vaccine CervarixTM, its protection for HPV CIN 2 lesions was 98.4% and 
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against CIN 3 lesions was 100%.4 It provided significant protection against non-oncogenic types 
such as HPV 33 and 45 . Both varieties of the HPV vaccine have been approved for use in South 
Africa.4 
 
The South African Human Papilloma Virus Advisory Board advocates that there should be 
universal immunization of young girls before the age of puberty, and that ideally this should be 
done between the ages of 9-12, where it is expected that girls have not had their sexual debut.4 
These vaccines are found to be extremely safe for use with no serious adverse effects.4 
The HPV vaccination of young girls has recently been rolled out by the Department of Health in 
conjunction with the Department of Education in South-Africa. The vaccine is administered in two 
doses, with the initial injection followed by the second after six months.9, 14  
   
The intention is to immunize young girls in grade 4 with the HPV vaccine with the aim of their 
developing immunity against HPV before they become sexually active. This slightly differs from 
the recommendation of the South African Human Papilloma Advisory Board’s recommendation 
that there should be universal immunization of young girls before the age of sexual debut, with 
vaccination preferably between 9 and 12 years of age in three doses commencing at 0, 1-2 months 
later, and a final dose at 6 months.4   The advisory board also advocates catch-up vaccination for 
females aged 13 to 26 years who have not been previously vaccinated .4  
 
It is generally accepted that vaccination against HPV is an important primary preventive measure. 
In terms of secondary prevention of cervical cancer, important methods are screening such as a 
visual inspection with acetic acid (VIA), visual inspection of the cervix after administration of 
Lugol’s iodine, and ultimately the use of the Pap smear. 
 
2.5  Healthcare workers knowledge of cervical cancer and cervical cancer screening 
 
Several studies indicate that knowledge of cervical cancer and cervical cancer screening amongst 
health workers is low.10, 16-19 
 
9 
In a study conducted in Haiti regarding health care workers knowledge of cervical cancer and 
screening, the researchers found that 69.2% of respondents did not have adequate knowledge about 
cervical cancer and cervical cancer prevention. The authors also found that among the participants 
who were knowledgeable about cervical cancer, 83.3% of those respondents identified HPV 
infection and multiple partners as risk factors for cervical cancer, while 92% of respondents felt 
that cervical cancer screening is an essential part of women’s health.10 
   
In 2012, a survey conducted in Jordan to assess awareness, practice and attitude to cervical Pap 
smears among female health care workers showed that up to half of the respondents were not aware 
of the availability of cervical cancer screening.11 
 
An older study conducted in Uganda which sought to assess knowledge, attitudes and practices on 
cervical cancer screening among medical workers, indicated that only 43% of respondents knew 
the risk factors for cervical cancer, eligibility for cervical cancer screening, and the screening 
interval; however, 93% of respondents in the study considered cervical cancer as a public health 
problem .The authors concluded that practical skills training on cervical cancer screening needed 
to be added to health care workers’ training curriculum.16 
 
In keeping with the predominant theme of inadequate knowledge of cervical cancer among health 
care workers, a study that was conducted in Turkey indicated that a large proportion of respondents 
in the study reported low knowledge of cervical cancer risk and inadequate screening practice. In 
this study, up to 24% of respondents had not heard of Pap smear testing and up to 40.5% of 
respondents did not know when one should be having Pap smear tests.17 
 
The results obtained in the Turkish study were  comparable to those obtained in a study done in 
Cameroon, in which the researchers concluded that knowledge of cervical cancer and its 
prevention by screening showed significant deficits, and that a massive amount of awareness had 
to be generated to ensure that the health care workers were up to date.18  In this study, only 58% 
of respondents were able to identify the most important risk factors for cervical cancer; however, 
86% of respondents were able to identify cervical cancer as a public health problem. 90% of 
respondents believed that cervical cancer screening could help prevent cervical cancer, while 84% 
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of respondents believed that this screening should be done with the aid of a Pap smear. There was 
a significant discrepancy in the knowledge of cervical cancer among different categories of health 
care workers, with nurses having the lowest levels of knowledge of cervical cancer and cervical 
cancer screening.18  
 
In a study evaluating knowledge of cervical cancer and its prevention among the nursing staff in a 
tertiary health institute in Gujarat, India, the researchers found that knowledge of cervical cancer 
among the health care workers was low, and that the knowledge of cervical cancer and its 
understanding needed to be improved drastically.19 
 
However, a few other  studies that  were  reviewed highlighted fairly high levels of knowledge of 
cervical cancer screening among respondents.20,21 In a study conducted in Thailand, the researchers 
found that knowledge  of medical workers about the importance of the Pap test, early detection of 
cervical cancer, and treatment of early stage cervical cancer was adequate.20 Another study 
conducted  in Eastern Nigeria, attempted to highlight awareness of health care workers to cervical 
cancer and cervical cancer screening. The results of the study found that 85% of respondents were 
aware of cervical cancer and 84.2% were aware of the fact that HPV causes cervical cancer. The 
authors also found that the awareness of cervical cancer screening was significantly higher than 
that of the HPV vaccine [OR: 0.17; 95% C.I: 0.09-0.30].21 
 
 A specific study in Mexico with respondents being family physicians, found that about 95.1% of 
the family physicians had adequate knowledge about the aetiology and prevention of cervical 
cancer, while up to 90.3% of the study respondents mentioned the Pap smear as the main method 
of diagnosis of cervical cancer. The reason adduced through this finding was the fact that the 
family physicians had gone through several years of training, including the attainment of 
postgraduate medical qualifications.22 The authors also found no significant difference in levels of 
knowledge between doctors working in urban and rural areas, and no significant differences in the 
levels of knowledge about cervical cancer among females and male participants.22 
 
There is an assertion that different categories of health workers might have differing levels of 
knowledge and awareness of cervical cancer. This premise was supported by a study conducted in 
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Tanzania, where the inference was that registered nurses seemed to have better knowledge 
compared to the enrolled nurses participating in the study.23     
 
The researchers found that less than half of the respondents in the Tanzanian study had adequate 
knowledge regarding cervical cancer and that there was a significant association between 
knowledge levels of causes of cervical cancer and the transmission of HPV, and age. The authors 
highlighted that the majority of the study respondents did not know the intervals for cervical cancer 
screening.23 
  
 2.6  Health care workers knowledge of HPV and HPV vaccination 
 
 A variety of studies have been done with objective of analysing the knowledge of health care 
workers about HPV and HPV vaccination.  A study in Cameroon by a group of researchers to 
determine the level of knowledge, awareness and beliefs of nurses about HPV and HPV vaccines 
concluded that the respondents had moderately low levels of knowledge regarding HPV infection 
and the prevention of cervical cancer, and moderately high levels of knowledge about the HPV 
vaccine. In this study, up to 32% of the respondents failed to identify HPV as a sexually transmitted 
infection, while up to 43.4% believed that it was an uncommon infection.24 It was concluded that 
despite the high levels of knowledge about the vaccine among the nurses, further education was 
needed to enable the health workers to increase their willingness to offer the vaccines to their 
patients.24  
 
In a 2010 study performed in Turkey among a team of health care workers working in specialties 
other than obstetrics and gynecology, the researchers found that physicians were more competent 
regarding the relation of HPV infection to cervical cancer, and were also more aware of the 
presence and types of HPV vaccine, which could ultimately manifest in a higher degree of 
willingness to prescribe the vaccine compared to non-physician health care providers.25  
 
In another study in which the objective was to determine family physicians’ knowledge and 
attitudes about the HPV vaccine, participants reported a higher intention to recommend both 
hypothetical HPV vaccine to girls vs. boys P<0.0001 and to older vs. younger adolescents P<0.001 
12 
The authors noted that the variables independently associated with the intention to recommend 
vaccination included female gender patients, knowledge about HPV, and fewer perceived barriers 
to vaccination.26 
 
According to a study conducted to determine female hospital health care workers knowledge of 
cervical cancer, HPV and HPV vaccination, only 12%–58.5% had some knowledge of HPV, and 
less than 50% had knowledge of HPV vaccination. 68%–85.3% of respondents had good 
knowledge of the Pap smear and cervical cancer. In this study, about 50–60% of the respondents 
had a good attitude towards HPV vaccination.27 
 
In a 2009 study in Thailand conducted among health care workers, Songthap and colleagues set 
out to determine the knowledge, attitude and acceptability of HPV vaccines among doctors and 
nurses. They found that knowledge on HPV was at a medium level, with approximately 80% of 
nurses and 63% of doctors agreeing on the use of the HPV vaccine. However, the nurses had a 
lower level of knowledge compared to the doctors in the study. The authors also found that about 
70% of both doctors and nurses would recommend the HPV vaccine to their clients.28  
 
In a study conducted among South African nurses, about three-quarters (73.3%) of the participants 
were aware of HPV and among them, 38.3% knew that HPV is the most common sexually 
transmitted virus. Nurses had poor knowledge regarding HPV infection and the HPV vaccine. The 
majority (90.9%) of the nurses intended to recommend the vaccine to their patients.32    
 
In another study conducted in Pretoria, South Africa, the researchers found that majority of the 
doctors involved in the study were aware of HPV; however they had poor knowledge regarding 
HPV infection and the HPV vaccine.  The authors concluded that there was a knowledge deficit 
regarding HPV. They proposed further education on safety and efficacy of the HPV vaccine for 
the doctors and the general public, in order to reduce the burden of cervical cancer .37  
 
There is a predominant theme of low level of knowledge of cervical cancer, HPV and HPV 
vaccination among health care workers.  Improving the level of education of health care workers 
could assist in reducing the burden of cervical cancer especially in resource poor areas. 32, 37 
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Although several of the studies assessing health care workers’ knowledge pertaining to cervical 
cancer, HPV and HPV vaccination have been reviewed, there seems to be a void pertaining to this 
subject, especially among health care workers in resource poor settings such as the North West 
province of South Africa. This provided the need for the researcher to investigate whether health 
care workers in this type of setting are knowledgeable about cervical cancer, HPV and HPV 
vaccination.  
 
2.7  Cervical cancer, HPV infection and HIV 
 
HPV infection has been identified as principal causative factor for a predominant percentage of 
cervical cancer cases .1, 2, 3   While several factors   such as early coitarche and smoking have 
being identified as risk factors for the development of cervical cancer, HIV positive status has 
been established as a significant risk factor in the development of cervical cancer. 33    
It has been proven that women infected with HIV have a significantly higher risk of development 
of cervical cancer and cervical dysplasia as compared to women who are not infected with 
HIV.34   South Africa has the highest number of people living with HIV in the world (an estimate 
of 5.7 million people aged 15 and above).35 Of these figure, 3.4 million are women.35 
In the natural course of HPV infection, a virile immune system is usually sufficient in the 
clearance of HPV with no further sequelae.2  It is however of significant importance that HIV 
positive patient have reduced immunity with subsequent increased susceptibility to the 
development of cervical cancer due to inability to clear HPV infection.  
In view of the above facts, it must be noted that the HIV/AIDS pandemic contributes immensely 
to the burden of cervical cancer in the country. 
This is quite alarming for a country like South Africa that has the largest number of people living 
with HIV as it denotes the epidemic of cervical cancer that can be unleashed if proper screening 
and management is not put in place.  
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Studies have highlighted the fact that there is fivefold to eightfold increased rate of abnormal 
smears in Human Immunodeficiency Virus-infected women. 36   One in five HIV-infected women 
with no evidence of cervical disease developed biopsy-confirmed squamous intraepithelial 
lesions within 3 years. These figures highlight the significant risk of the development of cervical 
cancer especially to patients living with HIV.36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER THREE   METHODS  
 
This chapter describes the aim, objectives and various components of the study (study design, the 
setting, the population, the sample size and selection, the procedures undertaken, and the data 
analysis).  
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3.1  Aims and Objectives 
 
The aim of the study was to assess the knowledge of primary health care workers in the Mamusa 
and Naledi sub-districts of the North West Province about cervical cancer, the human papilloma 
virus and the HPV vaccination. 
 3.1.2   Objectives 
 
1) To describe the socio-demographic profile of the different categories of primary health care 
workers in the study sample i.e. doctors, enrolled nurses, professional nurses, and clinical 
associates. 
2) To evaluate if primary health care workers in the Mamusa and Naledi sub–districts have 
adequate knowledge about cervical cancer. 
3) To evaluate if primary health care workers in the Mamusa and Naledi sub-districts have 
adequate knowledge about the human papilloma virus.  
4) To evaluate if primary health care workers in the Mamusa and Naledi sub-districts have 
adequate knowledge about HPV vaccination. 
5) To determine the association between knowledge levels of cervical cancer, HPV and HPV 
vaccination and the socio-demographic characteristics of the participants.   
 
3.2  Study setting 
 
The study was conducted in the health facilities in Mamusa and Naledi sub-districts of Dr Ruth 
Segomotsi Mompati District in the North West Province. In the Mamusa sub-district, this 
comprises a district hospital, one community health centre, and three clinics. These facilities are 
Schweizer-Reneke District Hospital, Mamusa Community Health Centre, Ipelegeng Clinic and 
Schweizer-Reneke Town Clinic. In the Naledi sub-district, the facilities in which the study was 
conducted included the Joe Morolong Memorial Hospital which was an exception as it offered 
both primary and secondary level of care and Huhudi Community Health Centre. 
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3.3  Study population 
 
The study population consisted of the different categories of primary health care workers in the 
health care facilities in the Mamusa and Naledi sub-districts.  For the purpose of this study, 
primary health care workers included categories of healthcare professionals such as doctors, 
clinical associates, enrolled nurses, enrolled nursing assistants, and professional nurses. Data 
obtained from the district offices indicated that 200 health workers from the different facilities 
were eligible for the study. Pharmacists were excluded from the study. 
 
3.4  Sample Size 
 
Using Epi Info Stat Calc, the confidence interval was set at 95% and a sample error of 5% was 
used with a power of 80%.  A power of 80% was chosen because a prior study done in Nigeria 
estimated the level of knowledge of health care workers about cervical cancer and HPV at 
82%.21 
It had been established that 200 health care workers from all the facilities were eligible for the 
study, therefore, 200 questionnaires were distributed in these study centres. Return numbered 116 
filled -in questionnaires, equating to a 58% response rate. During the study period, 65 health 
workers in the two sub-districts were on leave and 19 declined to participate in the study. 
 
3.5  Study design  
This was a descriptive cross-sectional study. 
 
3.6  Measuring tool 
The tool for this particular study was a self-administered questionnaire written in English, as it 
was expected that the primary health care worker respondents would clearly comprehend what was 
being asked of them. The questionnaire was adapted from two examples of validated 
questionnaires, 29, 30 and was divided into three main sections. The first section involved questions 
that aimed to collect basic socio-demographic data such as age, gender, level of education and 
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health care worker category.  The second section involved questions that assessed the respondent’s 
knowledge about cervical cancer and its prevention. This section was further divided into five sub-
sections, with the first sub-section dealing with the respondent’s general knowledge on cervical 
cancer.  
The next sub-section included enquiry about the relationship between stated risk factors and the 
development of cervical cancer; this aspect involved a Likert-like scale with a score of 0 to 2 
indicating a weak relationship between the stated risk factors and cervical cancer, and a score of 3 
to 5 indicating a strong relationship.  
The fourth series sub-sections included questions about the respondent’s knowledge of primary 
and secondary prevention of cervical cancer, with the final subsection containing questions about 
cytological examination.  The total of the number of questions assessing cervical cancer in all the 
subsections listed above totaled 37. 
The final section of the questionnaire involved assessment of the primary health care workers’ 
knowledge of the human papilloma virus and the HPV vaccine respectively. 
The aspect of the questionnaire testing the knowledge of primary health care workers about 
cervical cancer was derived from a slightly modified version of Cervical-Cancer-Knowledge-  
Prevention-64 (CCKP- 64) questionnaire was created by researchers in Poland for the purpose of 
testing the knowledge of respondents about cervical cancer and its prevention.29 
In the original CCKP-64 questionnaire, students were used for the study population. Due to this 
fact, certain aspects of the sociodemographic data were removed for the purpose of this study: for 
example, questions about the type of school /university attended. These questions were replaced 
by health care worker categories. Other details added to the socio-demographic section included 
race and highest level of education. Further changes involved the necessary replacement of 
‘Poland’ with ‘South Africa’ in the body of the questionnaire.  
For assessment of the knowledge of primary health care workers about HPV and HPV vaccination, 
this aspect of the questionnaire was derived from previous work done by researchers in Australia.30 
Permission was sought and received from both authors for the use of their questionnaire. 
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3.7  Data collection 
Data collection commenced after ethical approval for the study was obtained from the Human 
Research Ethics Committee (Medical) of the University of the Witwatersrand. Permission was 
obtained from the District Research Committee and the Sub-district managers in charge of the 
facilities that were included in the study.  
 
Data collection took place between 25 September 2016 and 1 November 2016. Team meetings in 
which a large proportion of the primary health care workers were available were targeted in 
conjunction with clinic and hospital management to ease the problem of availability of health 
workers for data collection i.e. for nurses, changeover of duty takes place in most of the facilities 
on Thursdays. Upon permission being obtained from the respective unit managers, the group of 
nurses were approached.  
 
The other categories of primary health care workers, such as the doctors and clinical associates, 
who were not as numerous as the nursing group, were approached individually. Primary health 
care workers were approached during a time convenient to them i.e. break time, so as not to impair 
the delivery of services in the facilities. A participant information sheet was given to the primary 
health workers prior to their receiving the questionnaires. This informed them about the study, the 
questionnaire and what would be expected of them in terms of their participation. The researcher 
informed all the primary health care workers that the information they provided would be treated 
with confidentiality. Primary health care workers were encouraged to fill in the questionnaires 
immediately, and the forms were collected by the researcher. However, for those who could not 
fill in the forms immediately, a sealable envelope was given them for the completed questionnaires 
in order to ensure confidentiality and safety of the documents.  
 
Questionnaires were then deposited in a sealed box placed in the wards of each institution, under 
the custodianship of unit managers who had the researcher’s permission and mandate to ensure the 
safety of the sealed submission boxes. The boxes had an opening for the insertion of the sealed 
questionnaires and once inserted, could be retrieved only by the researcher. 
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The primary health care workers were informed of the location of the sealed submission boxes. 
The questionnaires were kept in safety by the researcher upon their retrieval from the boxes. The 
data obtained from the questionnaires was then transferred to an MS Excel spreadsheet on the 
researcher’s computer, which was password-protected. 
 
3.8  Data Analysis 
 
Data was transferred to an MS Excel spreadsheet on the researcher’s computer, with coding done 
for categorical data. A total of 37 questions assessed respondents’ knowledge of cervical cancer, 
with their ability to answer 70 % of the questions correctly taken to mean that their level was 
adequate. The cut-off of 70% was chosen because a prior study done in Thailand estimated that 
the knowledge level of health care workers about cervical cancer and the Papanicolaou smear was 
between 68-85%.27 
Those respondents who answered less than 70% of this study’s questions correctly were deemed 
to have inadequate knowledge. The aspect of the questionnaire that tested for knowledge on HPV 
consisted of 22 questions in total. Adequate knowledge of HPV entailed primary health care 
workers answering 80% of the questions correctly i.e. 17 questions.    
The aspect that tested the knowledge of primary health care workers regarding HPV vaccination 
entailed seven questions. Adequate knowledge of HPV vaccination involved answering 70% of 
the questions correctly i.e. five questions. 
Data from the MS-Excel spreadsheet was imported to the statistical software (STATA vs. 14) for 
analysis. Categorical variables such as gender and job designation was analysed, with results 
presented as frequencies and percentages. Continuous variables such as age were presented as 
means and standard deviations. 
 
Fisher’s exact test and the chi square test were used in the comparison of variables. P value of < 
0.05 was considered significant.  
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3.9  Ethics  
 
The researcher obtained ethical clearance from the Human Research Ethics Committee (Medical) 
of the University of Witwatersrand (Certificate number M160312) to conduct the study.  
Permission was then sought and received from the District Research Committee and the sub-
district managers in charge of the respective facilities that were chosen for the study.  
A participant information sheet (Appendix B) was given to respondents to educate them about the 
study. Confidentiality and anonymity were maintained by ensuring that all completed 
questionnaires were kept under lock and key. Only those respondents who agreed to participate in 
the study took part; those who declined were not forced or coerced.  Their right to refuse was 
respected. 
 
3.10.  Funding 
 
The research was self-funded. 
 
 
 
 
 
CHAPTER FOUR     RESULTS 
  
This chapter presents the results of the data that was collected during the months of September to 
November 2016. 
4.1.  Methodology 
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A total of 200 questionnaires were distributed among primary health care workers in the Mamusa 
and Naledi sub-districts. A total of 116 were returned by participants from all the facilities and 
were then analysed. 
 
4.2. Demographics of the respondents  
Table 4.1:   Socio-demographics characteristics of the respondents  
Characteristics Frequencies (N=116) Percentages (%) 
Age distribution of respondents  
< 30 29 25 
30-39 49 42.2 
40-49 27 23.3 
50-59 11 9.5 
Percentage of respondents by gender  
Male  30 26 
Female  86 74 
Distribution by race  
Black 107 92 
Coloured  6 5.2 
White 
 
2 1.7 
Indian 1 0.9 
Distribution by institution  
Schweizer – Reneke District Hospital 39 33.6 
Joe Morolong Memorial Hospital 31 26.7 
Huhudi Community Health  Centre  24 20.7 
Mamusa CHC 12 10.3 
Ipelegeng Clinic 6 5.2 
Schweizer Reneke Town Clinic 4 3.4 
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Distribution by Professional category  
 
Enrolled Nursing assistant  19 16.4 
Enrolled Nurse 21 18.6 
Professional Nurse  67 57.8 
Clinical Associate  3 2.6 
Doctor 6 5.2 
 Highest Level of Education 
 
Less than Matric  5 4.3 
Matric 28 24.1 
Diploma  58 50 
Certificate  3 2.6 
Degree  22 19 
 
A majority of the respondents were in the 30–39 age group (42.2%, n=49/116). The mean age of 
the respondents was 36.6 ± 8.7 years. Female respondents made up 74% (n=86/116) of the study 
population.  As seen in Table 4.1 above, the largest proportion of the respondents were black (n= 
107/116, 92.2%). The majority of respondents worked at Schweizer-Reneke District Hospital 
(n=39/16, 33.6%).  
With regard to the distribution of the health care workers according to their professional category, 
most respondents were in the professional nurse category (n=67, 57.8%). With regard to levels of 
education, largest proportion of respondents were those with diplomas (n=58, 50%), followed by 
those with a matric (n =28, 24.1%).  
 
23 
4.3.  Knowledge of primary health care workers about cervical cancer 
4.3.1.  General knowledge about cervical cancer 
Table 4.2:  General knowledge about Cervical Cancer  
Questions Yes    No I don’t know  
Have you heard 
about cervical 
cancer? 
116          (100%) 0      (0 %) 0        (0% ) 
Can cervical cancer 
be a terminal illness? 
112           (96.5%) 2      (1.72%) 2        (1.72%) 
Can cervical cancer 
be associated with an 
infection? 
91            (78.4%) 20    (17.2%) 5        (4.3%) 
Is there an effective 
method that 
significantly reduces 
the risk of this 
disease? 
 
 
105           (90.5%) 
 
 
7      (6%) 
 
 
4       (3.4%) 
Have you ever had 
direct contact with 
the disease? 
 
43             (37%) 
 
62 (53.4%) 
 
11     (9.4%) 
Do you think this 
disease can affect you 
in future? 
 
64             (55.1%) 
 
32 (27.6%) 
 
30      (27.5%). 
 
All respondents in the study had heard of cervical cancer (n= 116,100%). 96.5% of the respondent 
felt that it was a terminal illness.  
About 17.2% (n= 20) of respondents did not think that cervical cancer could be associated with an 
infection.  
A large proportion of respondents (90.5%) felt that there was an effective method that could help 
reduce the risk of the disease. 
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4.3.2.  Relationship between estimated risk factors and occurrence of cervical cancer. 
Table 4.3:  The relationship between risk factors and the occurrence of cervical cancer  
RISK FACTORS  WEAK RELATIONSHIP STRONG RELATIONSHIP 
YOUNG AGE   75%         n= 82  25%          n=  28 
GENETIC FACTORS   13%         n= 13  87%          n=  97 
HPV   13%         n= 14  87%          n=  94 
HIV   11%         n= 12  89%          n=100 
MULTIPLE SEXUAL 
PARTNERS  
   6%         n= 6  94%          n= 104 
EARLY SEXUAL INTIATION    12%        n=12  88%          n= 92 
HISTORY OF STDS    9%          n=10  91%          n=98 
ALCOHOL ABUSE   69%         n=77  31%          n=38 
SMOKING   36%         n=41  64%          n=73 
MISCARRIAGES    38%         n=42  62%          n=67 
MULTIPARITY   31%         n=34  69%          n=70 
EARLY MENARCHE   68%         n=78  32%          n=36 
USE OF CONDOMS   91%         n=103   9%           n=10 
HORMONAL 
CONTRACEPTION 
  70%         n=73  30%          n=31 
BREASTFEEDING   85%         n= 98  15%          n=17 
USE OF PSYCHOACTIVE 
SUBSTANCE 
 77%          n=83  23%          n=25 
USE OF PUBLIC SWIMMING 
POOL 
 93%         n=100  7%           n=14 
 
The majority of respondents correctly identified the strong relationship between HPV, HIV, 
multiple sexual partners and early sexual debut with the occurrence of cervical cancer.  87%, 89%, 
94% and 88% of the respondents respectively, correctly identified these risk factors as having a 
strong relationship to the development of cervical cancer. 93% of respondents identified the use 
25 
of a public swimming pool as having a weak relationship to the development of cervical cancer, 
however, about a third of the respondents didn’t know about the strong relationship between 
smoking and the development of cervical cancer. About two thirds of the respondents also thought 
that early menarche had a weak relationship to the development of cervical cancer. 
4.3.3.      Knowledge about primary prevention of cervical cancer  
  
4.3.3.1     Lifestyle  
 
Table 4.4: Knowledge of risk factors for the development of cervical cancer 
 
 Yes               % No             % I don’t know       %    
A diet rich in anti- 
oxidants 
54                (47%) 26              (22%)  36                    (31%)                    
Regular physical 
exercise 
72                (63%) 35              (30%)  8                       (7%) 
Use of vitamin 
supplements  
55                (49%) 44              (39%) 13                     (12%) 
Proper long and 
relaxing sleep 
53                (47%) 40              (35%) 20                     (18%) 
Avoiding highly 
processed food 
46                (41%) 36              (32%) 30                     (27%) 
Weight loss 34                 (31%) 62               (56%) 15                     (13% 
Restraint from 
casual sex 
84                 (76%) 22              (20%) 4                        (4%) 
 
Table 4.4 above demonstrates that a large proportion of the respondents (63%) felt that regular 
physical exercise could reduce the risk of developing cervical cancer, and about half the 
respondents felt that use of vitamin supplements could reduce the risk of developing cervical 
cancer.  
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4.3.3.2.     Vaccines  
 
Table 4.5:  Knowledge about primary prevention of cervical cancer (Vaccines) 
   Yes  No  I don’t know  
Have you heard 
about the vaccine 
against cervical 
cancer? 
  74       (65%)   29              (26% )           10                 (9%) 
If such a vaccine 
exists, is it available 
in South Africa? 
 
   83        (72%)    11              (10%)   22                 (19%) 
Is it free of charge?   73          (63%)    18              (16%)  25                   (21%) 
Does it guarantee 
100% protection 
from cervical 
cancer? 
  11       (10%)    70              (60%)  35                   (30%) 
Do you know where 
to get vaccinated?  
 79          (68%)    17                 15%)                                    20                    (17%) 
Have you ever been 
vaccinated? 
 9             (8%)  96                  (83%) 11                     (9%) 
 
As seen in Table 4.5 above, a majority of the study participants had heard about the vaccine against 
cervical cancer (65% n= 74/113) however, up to 19 % ( n= 22/116) of the respondents were not 
aware of its availability in South Africa. A large proportion of the health care workers had not 
been vaccinated against cervical cancer 83% n= 96/116). 
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Figure 4.1:  Ideal age reported by participants for HPV vaccination 
In Figure 4.1 above, the majority of respondents (n= 68,58.6%) correctly indicated that the vaccine 
for primary prevention of cervical cancer should be administered between the ages of 9-13 years. 
16.3 % of the respondents felt that the age for administration of the vaccine should be 8 years.  
8.6% of the respondents did not know the recommended age for vaccination.  
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4.3.4.       Knowledge about secondary prevention of cervical cancer  
 
Table 4.6:  Knowledge of secondary prevention of cervical cancer reported by participants  
 Yes                  % No                    % I  don’t know    % 
Lack of symptoms 
from genital areas 
39                   (35%) 62                  (55%) 12                   (10%)                    
Painful menstruation 82                   (73%) 25                  (22%) 4                      (5%) 
Intensive 
/intermenstrual 
bleeding 
95                    (84%) 14                  (12%) 4                      (4%) 
Irregular 
menstruation/ lack of 
menstruation 
84                     (72%) 26                   (23%) 6                      (5%) 
Smelly vaginal 
discharge 
97                     (87%) 11                    (10%) 3                      (3%) 
Itchy rash in the 
genital area 
79                    (68%) 34                    (29%) 3                      (3%) 
Bleeding after 
intercourse 
99                    (88%) 7                       (6%) 7                      (6%) 
High fever  62                    (54%) 33                     (29%) 19                    (17%) 
 
In Table 4.6 above, a large majority of the respondents (73%) felt that painful menstruation was a 
common symptom of cervical cancer, while up to 88% of respondents felt that post-coital bleeding 
was an important symptom of cervical cancer. 
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4.3.5.  Knowledge of Pap smear / cytological examination 
Table 4.7:  Knowledge of the pap-smear /cytological examination reported by 
participants  
 Yes  No                           I don’t know 
Have you heard of 
pap smear? 
108               (96%) 4                      (4%)   0              (0%) 
Is it a test that gives 
you 100% chance of 
early diagnosis? 
100               (89%) 12                   (10%)  1               (1%) 
Is the test painful? 13                  (12%) 89                    (79%) 10              (9%) 
Is it a time- 
consuming test?  
24                  (22%) 83                    (75%)  4               (3%) 
In South Africa, is it 
possible to be tested 
free of charge?   
112                 (99%) 1                       (1%)  0               (0%) 
Does having the test 
done eliminate the 
lifetime risk of 
cervical cancer? 
22                    (19%)  92                   (81%) 0                (0%) 
Can the test cause 
serious 
complications? 
6                      (5%) 102                   (90%) 5                (5%) 
Is it possible for the 
Pap smear to 
increase your 
chances of cervical in 
the future?  
8                       (7%) 99                    (88%) 5                (5%) 
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96% of the respondents (n=108) in Table 4.7 above had heard of the Pap smear, while up to 12% 
of respondents felt that it was a painful test. 
 
 
Figure 4.2: Time interval for doing the Pap test  
It is demonstrated in the above Figure that about 71% of the respondents felt that the Pap test 
should be done annually. 
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Figure 4.3:  Age at which women should take the Pap smear 
About 43% of the respondents felt that the Pap test can be done at any age, as shown in Figure 4.3 
above. 
Table 4.8:   Time at which a woman should undergo the Pap smear after sexual debut 
 < I year  1-3years  4-6 years  
How long after sexual 
debut should women 
undergo the pap test?  
79                   (72%) 26                   (24%)  5                    (4%) 
 
Table 4.8 above shows that 72% (n= 79) of the respondents felt that women should undertake the 
pap smear test within a year after sexual debut. 
50, 45%
17, 15%2, 2%
43, 38% 17-25
26-59
>60
Any age
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Figure 4.4: Participants’ knowledge of cervical cancer  
Only 26% (30/116) of the respondents had adequate knowledge about cervical cancer. 
4.3.5.1.       Source of information about cervical cancer 
 
   
 
Figure 4.5:  Source of information about cervical cancer  
With regard to the source of information about cervical cancer, the majority of respondents in 
Figure 4.5 obtained their information from various sources other than the ones listed in the 
questionnaire. This was followed by respondents receiving information about cervical cancer from 
the doctors. Other sources of information about cervical cancer chosen by the respondents included 
the internet, television, schools and newspaper 
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4.4.  Knowledge of the Human papilloma virus (HPV) 
Table 4.9:   Knowledge of HPV 
 True   False  
HPV is very rare                                       25                 (23%) 84            (77%) 
HPV has visible signs or symptoms         63                 (59%) 43            (41%) 
HPV can cause cervical cancer 94                 (88%) 13            (12%) 
HPV can be passed on by genital skin-to-skin contact           84                 (78%) 24             (22%) 
There are many types of HPV                85                 (79%)  23             (21%) 
HPV can cause HIV/AIDS                     39                 (35%) 71             (65%) 
HPV can be passed on during sexual intercourse            84                 (81%) 20             (19%) 
HPV can cause genital warts              85                 (79%) 23             (21%) 
Men cannot get HPV                          23                 (21%) 86             (79%) 
Using condoms reduces the risk of getting HPV           80                 (74%) 28             (26%) 
HPV can be cured with antibiotics             33                 (32%) 71             (68%) 
Having many sexual partners increases the risk of getting 
HPV         
98                 (91%) 10              (9%) 
HPV usually doesn’t need any treatment        23                 (21%) 86             (79%) 
Most sexually active people will get HPV at some point in 
their lives        
83                 (78%) 24             (22%) 
A person could have HPV for many years without knowing 
it      
94                 (85%) 16             (15%) 
Having sex at an early age increases the risk of getting HPV        95                (88%) 13             (12%) 
An HPV test can show for how long you have had an HPV 
infection        
38                (36%) 69             (64%) 
If a woman tests positive for HPV she will definitely get 
cervical cancer        
61                 (55%) 50             (45%) 
An HPV test can be done at the same time as a [Pap 
test/Smear test/Pap smear test]                    
75                 (69%) 34             (31%) 
HPV testing is used to indicate if the HPV vaccine is needed        50                 (47%) 56             (53%) 
When you have an HPV test, you get the results the same 
day       
22                 (21%) 83             (79%) 
If an HPV test shows that a woman does not have HPV, her 
risk of cervical cancer is low               
73                 (68%) 34             (32%) 
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59% of the respondents felt that HPV has visible signs and symptoms, while up to 32% felt it could 
be cured by antibiotics. 
4.5.  Knowledge of HPV vaccination  
 
With regard to knowledge of HPV vaccination among respondents in the study, results showed 
that 67.2% (n = 78) had adequate knowledge regarding HPVvaccination compared to 32.8% 
(n=38) who had inadequate knowledge of HPV vaccination. 
 
Table 4.10:  Knowledge of HPVvaccination 
 True False 
HPV vaccination requires two doses 67     (61%)  43    (39%) 
The HPV vaccine offers protection against all sexually transmitted 
infections 
23     (21%) 88    (79%) 
The HPV vaccine is most effective if given to people who have never had sex 82     (76%) 26    (24%) 
Someone who has had HPV vaccination cannot develop cervical cancer        20     (19%) 88    (71%) 
The HPV vaccine offers protection against most cervical cancers      68     (62%) 41    (38%) 
One of the HPV vaccines offers protection against genital warts         61     (57%) 46    (43%) 
Girls who have had the HPV vaccination do not need a [Pap test/Smear 
test/Pap smear test] when they are older             
7        (6%) 103  (94%) 
 
Table 4.10 above shows that 21% of the respondents believed that HPV vaccination offers 
protection against all sexually transmitted infection. 
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4.6. Participants’ knowledge on cervical cancer, HPV and HPV vaccination 
 
 
 
Figure 4.6:  Participants’ knowledge on cervical cancer, HPV and HPV vaccination 
In this study, 26% (30/116) of participants had adequate knowledge of cervical cancer. Adequate 
knowledge of HPV was seen in 41% of the participants (48/116) and 67% of the participants had 
adequate knowledge of the HPV vaccine (78/116). 
 
30
48
78
86
68
38
Cervical Cancer HPV HPV vaccine
Adequate knowledge  of the participants
Inadequate knowledge of the participants
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4.7.  Association between knowledge of cervical cancer, HPV, HPV vaccination and 
sociodemographic characteristics. 
Table 4.11:  Correlation of knowledge level of cervical cancer with health care category 
 Inadequate knowledge 
N= 86 
Adequate knowledge 
N= 30 
p=0.016 
Enrolled nursing assistant  
n=19 
17       (89%)  2   (11%) 
Enrolled nurse n= 21 16        (76%) 5     (24%) 
Professional nurse n= 67 50        (75%) 17   (25%) 
Clinical associate n= 3  2         (67%) 1     (33%) 
Doctor n=6 1           (17%) 5      (83% 
Chi square test p= 0.016  
Table 4.11 above shows that doctors were more knowledgeable about cervical cancer compared 
to enrolled nursing assistants (Table 4.11) 
Table 4.12:  Correlation of knowledge of cervical cancer with highest level of education 
 Inadequate Knowledge   
N= 86 
Adequate knowledge N= 30 p=0.014 
Less than matric n=5 5       (100%)  0   (0%) 
Matric n= 28 25        (89%) 3     (11%) 
Diploma n= 58 43        (74%) 15   (26%) 
Certificate n= 3  1        (33%) 2     (67%) 
Degree n=6 12         (55%) 10    (45% 
Chi square test p= 0.014 
Less than a matric qualification was synonymous with lack of knowledge about cervical cancer 
(Table 4.12).   
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Table 4.13:  Correlation of knowledge of cervical cancer and age group 
 INADEQUATE 
KNOWLEDGE   N= 86 
ADEQUATE 
KNOWLEDGE N= 30 
p=0.164 
Less than 30 
n=29 
22      (76%)  7  (24%) 
30-39 n= 49 32       (65%) 17 (35%) 
40-49 n= 27 24       (89%) 3 (11%) 
 50 n= 11  8       (73%) 2    (27%) 
Chi square test p= 0.164 
Respondents in the age group 40-49 had a significant proportion without adequate knowledge 
about cervical cancer compared to the other age groups (Table 4.13).   
 
Table 4.14:  Correlation of knowledge of cervical cancer and place of work 
 INADEQUATE 
KNOWLEDGE 
N=86 
ADEQUATE 
KNOWLEDGE 
N=30 
P value 
p =0.044  
 n  (%) n (%)    
Schweizer-Reneke 
District Hospital: n= 39 
24 (61) 15 (38) 
Joe Morolong Memorial 
Hospital:  n= 31 
23 (74) 8 (26) 
Huhudi Community   
Health Centre: n=24  
 23  (4) 1 (4) 
Mamusa Community 
health centre: n=12 
 9 (75)  3(25) 
Ipelegeng clinic: n=6   4 (67)  2 (33) 
Schweizer-Reneke 
Town Clinic: n=4 
   
  3 (75) 
 
 1(25) 
Chi square test p= 0.044 
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The largest proportion of staffers at Joe Morolong Memorial Hospital had less than adequate 
knowledge of cervical cancer compared to the other institutions (Table 4.14). 
 
Table 4.15:  Correlation of knowledge level of HPV with health care worker category  
 INADEQUATE 
KNOWLEDGE 
N=68  
ADEQUATE  
KNOWLEDGE  
N=48 
P value 
Enrolled nursing 
assistant: n=19 
13 (68) 6 (32) p <0.001 
Enrolled nurse: 
n=21 
20 (95)  1 (5) 
Professional nurse: 
n=67 
35 (52) 32 (48) 
Clinical associate: 
n=3 
 0 (0)  3 (100) 
Doctor: n=6  0  (0)  6 (100) 
Fisher exact test        P value < 0.0001 
As shown in Table 4.15, doctors were more knowledgeable about HPV than other health care 
worker categories. 
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Table 4.16:  Correlation of knowledge of HPV and highest level of education 
 
 INADEQUATE 
KNOWLEDGE 
n=68 
ADEQUATE 
KNOWLEDGE  
n= 48  
P value = 0.001 
< than Matric: n=5 4  (80) 1 (20  
Matric: n= 28 23 (81) 5 (19) 
Diploma: n=58 34 (59) 24 (41) 
Certificate: n=3  1  (33) 2 (67) 
Degree:  n= 22 6  (27) 16 (73) 
Fisher exact test p=0.001 
There was significant association between knowledge of HPV and the highest level of education 
(p =0.001). Degree holders had significantly more knowledge of HPV compared to those with a 
matric certificate. (Table 4.16). 
Table 4.17:  Correlation of knowledge of HPV and age group 
AGE GROUP INADEQUATE 
KNOWLEDGE 
ADEQUATE 
KNOWLEDGE 
P value 
 n  (%) n (%)    p =0.375 
< than 30: n= 29 13 (45) 16 (55) 
30-39: n=49 30 (61) 19 (39) 
40-49: n= 27 18 (67 ) 9 (33) 
50-59: n= 11 7  (64) 4 (36) 
Fischer exact test p= 0.375 
In Table 4.17, the younger age group had more knowledge compared to the other age groups. 
There was no association between knowledge of HPV and gender (p= 0.123), race (p= 0.587) and 
place of work (p= 0.141). 
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Table 4.18:  Correlation of knowledge of HPV vaccination and health care worker 
category 
 INADEQUATE 
KNOWLEDGE 
ADEQUATE 
KNOWLEDGE  
P value 
 n  (% )   N (%)    p =0.043  
Enrolled nursing 
assistant: n= 19 
7 (37) 12 (63) 
Enrolled nurse= 21   11 (52) 10 (48) 
Professional nurse: 
n= 67  
18 (27) 49 (73) 
Clinical associate: 
n= 3 
 2 (67)  1 (33) 
Doctor: n= 6   0 (0)  6 (100) 
Fisher exact test p= 0.043 
In Table 4.18, doctors had more knowledge of HPV vaccination (100%) compared to enrolled 
nurses (48%) and enrolled nursing assistants (64%). There was a significant association between 
knowledge of HPV vaccination and the health care worker category (p= 0.043). 
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Table 4.19:  Correlation of knowledge of HPV vaccination and place of work  
 
 INADEQUATE 
KNOWLEDGE 
ADEQUATE 
KNOWLEDGE 
P value 
p =0.002  
 n  (%) n (%)    
Schweizer-Reneke District 
Hospital: n= 39 
13 (33) 26 (67) 
Joe Morolong Memorial 
Hospital:  n= 31 
14 (45) 17 (55) 
Huhudi Community   
Health Centre: n=24  
 1  (4) 23 (96) 
Mamusa Community 
Health Centre: n=12 
 7 (58)  5(42) 
Ipelegeng clinic: n=6   1 (17)  5 (83) 
Schweizer Reneke Town 
Clinic: n=4 
   
  2 (50) 
 
 2(50) 
Fisher exact test p= 0.002 
There was also a significant association between knowledge of HPV vaccination and the 
respondents’ place of work (p= 0.002). Health care workers at Joe Morolong Memorial Hospital 
had more knowledge of HPV vaccination compared to that in the hospitals (Table 4.19). 
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Table 4.20:  Correlation of knowledge of HPV vaccination and highest level of education 
 INADEQUATE 
KNOWLEDGE  
ADEQUATE 
KNOWLEDGE 
P value 
p =0.010 
 n  (%)  N (%)    
< than Matric: n=5 3 (60) 2 (40) 
Matric: n= 28 13 (46) 15 (54) 
Diploma: n= 58 14 (24) 44 (76) 
Certificate=3  3  (100) 0 (0) 
Degree: n=  5  (23) 17 (77) 
Fischer exact test p= 0.010 
There was a significant association between knowledge of HPV vaccination and the highest 
educational level attained by the respondents (p= 0.010). Respondents with a higher educational 
attainment had more knowledge regarding HPV vaccination compared to those with less 
educational attainment (Table 4.20).   
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4.8:  Logistic regression of socio-demographic factors having significant association with 
knowledge of cervical cancer  
Table 4.21:  Logistic regression of socio-demographic factors having significant 
association with knowledge of cervical cancer  
 Variables Odds ratio P value 95% Confidence interval 
Place of work    
JMMH 0.5565217 0.265 0.1984451 - 1.560716 
HUHUDI CHC 0.0695652 0.013 0.0084891 - 0.5700629 
MCHC 0.5333333 0.398 0.1242049 - 2.290123 
IPELEGENG CLINIC 0.8 0.810 0.1301618 - 4.916959 
SRTC 0.5333333 0.601 0.0506951 - 5.610887 
Different categories of health workers    
Enrolled nurse  2.65625    0.281 0.4496259 - 15.6923 
 Professional nurse  2.89    0.184 0.6042122 - 13.82312 
Clinical Associate  4.25    0.313 0.25529 - 70.75287 
Doctor  42.49999    0.005 3.158784 - 571.818 
Educational background    
Matric 0.144 0.009 0.0333642 - 0.6215053 
Diploma  0.4186047 0.096 0.1502616 - 01.166165 
Certificate  2.4 0.500 0.188727 - 030.52028 
 
Health care workers at Huhudi CHC had 6.9% less knowledge of cervical cancer compared to 
workers at Schweizer-Reneke DH, (odds ratio 0.0695652, p value 0.013, 95% CI 0.0084891 - 
0.5700629), as shown in Table 4.21. 
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Doctors were 42.5 times more knowledgeable about cervical cancer when compared to enrolled 
nursing assistants. This association was strongly significant with a p value of 0.005, odds ratio of 
42.49 and a 95% confidence interval of [3.158784 - 571.818].  
With regard to levels of education, only participants with matric qualification demonstrated a 
statistically significant association with knowledge of cervical cancer. This group of participants 
were found to be 14.4% less knowledgeable on cervical cancer compared to participants with less 
than matric qualification, (odds ratio 0.144, p value 0.009 and 95% CI of 0.0333642 - 0.6215053).  
Table 4.22:  Logistic regression of socio-demographic factors with significant association 
with knowledge of HPV 
  Odds ratio P value 95% Confidence interval 
Different categories of health workers 
Enrolled nurses 0.1083333 0.051 0.0116584 – 1.006666 
 Professional nurses  1.980952 0.215 0.67299 – 5.830952 
Enrolled nursing assistant  1 -             - 
Clinical Associate  1 -            - 
Educational status of the health workers 
Matric 0.8695652 0.909 0.0792622 – 9.539774 
Diploma 2.823529 0.366 0.2967815 – 26.86259 
Certificate 8 0.210 0.3101215 – 206.3707 
Degree 10.66667 0.052 0.983533-115.6827 
 
In Table 4.22, there was no statistically significant association between HPV knowledge and 
health care worker category and level of education of health care worker when applying logistic 
regression analysis.  
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Table 4.23:  Logistic regression of socio-demographic factors with significant association 
with knowledge of HPV vaccination 
  Odd ratio P value 95% Confidence interval 
Place of work 
JMMH 0.6071429 0.314 0.2298373 - 1.603841 
HUHUDI CHC 11.49999 0.023 1.394361 - 94.84619 
MCHC 0.3571429 0.128 0.0947618 - 1.346017 
IPELEGENG CLINIC 2.5 0.424 0.2640554 - 23.66927 
SRTC 0.5 0.512 0.0630959 - 3.962224 
Different categories of health workers 
Enrolled nursing 
assistant  1 - - 
Enrolled Nurse 0.530303 0.326 0.1495514 - 1.880432 
 Professional Nurse 1.587963 0.400 0.5406886 - 4.663732 
Clinical Associate 0.2916668 0.348 0.0222095 - 3.830314 
Doctors  1 - - 
Educational status    
Less than matric 1 - - 
Certificate 1 - - 
Matric 1.730768 0.579 0.2494113 - 12.01051 
Diploma 4.714282 0.107 0.7139296 - 31.12975 
Degree 5.099996 0.119 0.6576738 -  39.54841 
 
Health care workers at Huhudi CHC were 11.5 times more knowledgeable about HPV 
vaccination compared to workers at SRDH, (odds ratio 11.49999, p value 0.023, 95%, CI 
1.394361 – 94.84619). No statistically significant associations were detected with other places of 
work and knowledge of HPV vaccination when using logistic regression.  
There was no statistically significant association between knowledge of HPV vaccination and 
health care worker category and level of education of the health workers when using logistic 
regression (Table 4.23). 
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CHAPTER FIVE      DISCUSSION 
5.1.  Discussion 
 
This chapter discusses the results of this study extensively in relation to other articles/studies. 
The purpose of the study was to determine if  primary health care workers in the Mamusa and 
Naledi sub-districts had adequate knowledge of  cervical cancer, HPV and HPV vaccination  
(Pertinent observations derived from the study are examined in this chapter.  
 
5.2  Sociodemographic characteristics 
 
In terms of the ages of the study respondents, it was noted that the majority fell in the 30-39 age 
group (n= 49, 42.2%). A significant proportion of the study population was observed to be those 
in the < 30 age group to those in the age group 40-49 years. This observation was expected as these 
age ranges generally form the bulk of working-class age groups. The mean age of the respondents 
in the study was 36. This was similar to the mean age of the respondents in other similar studies, 
in which mean ages were 34, 32.5 and 30.6 respectively.10, 20, 21 
With regard to the place of work of respondents, the majority were found to be in the hospitals as 
compared to the clinics and health centres.  33.6% and 26.7% of the respondents worked at 
Schweizer-Reneke District Hospital and Joe Morolong Memorial Hospital respectively. A total of 
40 % of the respondents were working at the different clinics and the health centre in the Mamusa 
and Naledi sub-districts. This was to be expected as the hospitals are bigger in size and scope, and 
more health care workers are registered to work in the hospitals compared to the clinics and health 
centre. 
In terms of the gender distribution of the respondents, 26% were male and 74% were female. 
Nurses were the majority of the respondents in this study. A total of 92% of the respondents in the 
study were nurses, with 8% from other health care professions such as doctors and clinical 
associates. A similar study done in Jordan involving health care workers had close to 50% of the 
respondents being nurses.11 Nurses form the backbone of the primary health care sector and as 
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such, it could be expected that they would make up a significant proportion of the respondents in 
any study having primary health care workers as its respondents. 
 
5.3  Knowledge of cervical cancer 
 
The study revealed that only 26% of respondents had adequate knowledge of cervical cancer. This 
finding is similar to results obtained from other studies that concluded that health care workers had 
limited knowledge about cervical cancer. 18, 21, 23    However, our result differed from other studies 
which stated that a significant proportion of the health care workers had adequate knowledge of 
cervical cancer.19, 24  
The results revealed a significant gap in the level of knowledge of the study’s primary health 
workers. This needs to be dealt with as they are primarily responsible for the fight against cervical 
cancer, and it would be worthwhile for them to be sufficiently knowledgeable about the subject 
while disseminating information to the clients they serve. 
In this study, there was no significant association between knowledge of cervical cancer and age 
group, gender and race, however, there was significant association between knowledge of cervical 
cancer and the health care workers’ categories of place of work and highest educational levels. 
 In a study done in Cameroon among nurses, the researchers found that nurses had moderately low 
levels of knowledge of prevention of cervical cancer.2 4 In a similar study done in Canada among 
health care practitioners, knowledge of cervical cancer was found to be at a medium level.26   Both 
these results were in keeping with the findings of this study. 
 In the study, the highest levels of adequate knowledge of cervical cancer were found in doctors 
(83%) vs. (11 %) for enrolled nursing assistants.  
A reason that can be adduced for this finding is that doctors have gone through an extensive period 
of training in medicine and as such, would be expected to have significantly more knowledge 
compared to enrolled nursing assistants who have undergone training for a significantly shorter 
period of time. 
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A series of questions were asked in an attempt to establish respondent’s knowledge of cervical 
cancer. One hundred percent of the respondents indicated that they have heard about cervical 
cancer; this was significantly higher than the figures obtained in a similar study that was done in 
Mdantsane in the Eastern Cape province, with 60% indicating that they had heard about cervical 
cancer.3 In a study done in Jordan, only 53.5% of the respondents were found  to be aware of 
cervical cancer and its prevention.11  Our result was more in keeping with those obtained in another 
study in Nigeria, in which the researchers found that 91% of the health care workers were aware 
of cervical cancer.21  Cervical cancer is a fairly common disease, hence it would be expected that 
a significant majority of primary health care professionals would have heard of it.  
Results obtained from our study indicated that 78.4% of respondents thought that cervical cancer 
could be associated with an infection. This was lower than results obtained in a study in Cameroon, 
where up to 90.8% correctly identified that cervical cancer was directly linked to HPV infection. 
However, the drawback to this finding was the fact that up to 32% of the respondents in the study 
failed to identify HPV as a sexually transmitted infection.24 The discrepancy in the findings 
between the two studies could possibly be due to a differing quality of health education between 
the two countries.  
The majority of respondents in this study were able to recognize the strong relationship between 
HPV, HIV, multiple sexual partners and a history of sexually transmitted diseases as significant 
risk factors for the occurrence of cervical cancer. However, it was noted in the study that more 
than a third of the respondents did not associate smoking as a strong risk factor in the development 
of cervical cancer. A large number of respondents felt that physical exercise and use of vitamins 
could reduce the risk of developing cervical cancer. 
With regard to the use of vaccine as a means of primary prevention of cervical cancer, in this study, 
only 65 % of respondents had heard about the HPV vaccine and knew that it was free of charge, 
but only 10% knew that it protects from cervical cancer. This was an alarming finding as it 
indicated that at least one third of the study population was not aware of such a vaccine. This has 
huge public health implications as these primary health care workers are not in a position to fully 
educate their patients about cervical cancer if they are not aware of the existence of the vaccine. 
This result was similar to that obtained in the Nigerian study, in which only 62.7% of the 
respondents were aware of the HPV vaccine.21 It should also be noted that about 59% of the 
49 
 
respondents in this study knew the recommended age for vaccination in school children, and only 
59% of the participants knew the correct age for the administration of the vaccine. A majority of 
the participants could identify most of the symptoms of cervical cancer, which showed that they 
had knowledge of the symptoms, however, their broad knowledge of cervical cancer was low. This 
might be the reason for the low score shown for adequate knowledge of cervical cancer. 
Though the national guidelines state that a Pap smear should be done once in three years for healthy 
women, 80% of the respondents felt that a Pap smear should be done annually, and 50% felt that 
the Pap smear should be done between the ages of 17-25years. No literature that spoke in this 
regard was found.  
With regard to the sources of information about cervical cancer, the majority of respondents 
obtained their information from various sources other than those listed in the study’s questionnaire. 
It was established that respondents received information about cervical cancer from the doctors. 
Other sources of information chosen by the respondents included the internet, television, schools 
and newspapers. Cumulatively, sources other than health care professionals as a source of 
information about cervical cancer were more prevalent when compared to health care professionals 
as a source of information regarding cervical cancer. The questionnaire used for the study was 
initially designed for students hence sources of information that may have applied specifically to 
healthcare workers such as continuous professional development meetings   was not listed among 
the options. 
In a study done in East London, South Africa, about 40% of the respondents obtained their 
information from clinics.3 In another study done in Jordan, a majority of the respondents obtained 
their information from medical literature.11 These findings differed from the findings of this study.  
While the impact of the internet and news media cannot be denied as a vital source of health 
information for the populace, health professionals are a vital component in the dissemination of 
health information, and it is particularly worrying that a majority of this study’s respondents 
obtained their information from sources other than health care practitioners. Health care 
practitioners should be encouraged to disseminate information to their patients regarding cervical 
cancer, HPV and HPV vaccination.  
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5.4  Knowledge of HPV 
  
It was indicated in this study that 41% (n= 48) of participants had adequate knowledge of HPV.   
This was a particularly low figure when compared to a study among family physicians in Mexico, 
that indicated that about 95% of their respondents had knowledge of HPV as a main etiological 
agent for cervical cancer.22  This significant difference could result from a difference in study 
population, with this study containing a pool of different categories of primary health care workers, 
and the Mexican study containing only family physicians, who are expected to have had 
significantly more medical training compared to other health care providers. This study’s results 
compare favourably with a study done in Thailand, which indicated that 12-58.3% of respondents 
had some knowledge of HPV.27 Another group of researchers, also in Thailand, noted that 
knowledge of HPV by health care providers was at a medium level.28 
The fact that health care workers’ knowledge of HPV is low should be concerning, particularly 
given the fact that it is the primary cause of cervical cancer. Health care workers are in the forefront 
of the fight against cervical cancer and should be expected to be knowledgeable about HPV. 
This study found a significant association between the knowledge of HPV and the health care 
worker category (p < 0.001). Doctors were more knowledgeable about HPV than enrolled nurses 
and enrolled nursing assistants. There is a paucity of such studies, hence comparisons were 
difficult to make.   
However, it was found that there is no significant association between knowledge of HPV and age 
group, gender, race, and place of work. 
5.5  Knowledge of HPV vaccination 
 
67% of the participants had adequate knowledge of the HPV vaccine. 61% knew that there are two 
different vaccines, and 76% believed that the vaccine was most effective in people who had never 
had sex. 62% of the participants felt that the HPV vaccine was protective against most cervical 
cancer types.   
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More than half of the study’s participants (59%) knew the correct age for HPV vaccination. In 
terms of knowledge of HPV vaccination itself, the study found that compared to health care 
workers knowledge of HPV, the level of knowledge about HPV vaccination was fairly high. With 
regard to the knowledge of HPV vaccination among the respondents in the study, the results 
obtained from the study showed that 67.2% (n = 78) of the respondents had adequate knowledge 
regarding HPV vaccination compared to 32.8 % (n=38) of the respondents without adequate 
knowledge of HPV vaccination. 
This figure was significantly higher than that obtained in a study done in Haiti, in which only 27% 
of the respondents were aware of the HPV vaccine.10 The levels of awareness of HPV vaccination 
in another study was 62.7%.21 This was comparable to that obtained in this study. Another study 
among nurses in Cameroon found that the respondents had a moderately high level of knowledge 
of HPV vaccination.24 Health care workers are responsible for the dissemination of health care 
information and as such, this represented a significant gap in their knowledge of HPV vaccination 
.  
 
This study found that doctors had more knowledge of HPV vaccination (100%) compared to 
enrolled nursing assistants (64%), and enrolled nurses (48%). A dichotomy between knowledge 
levels of doctors and clinical associates as compared to enrolled nursing assistants and enrolled 
nurses was noted. This finding was corroborated by such a finding in another study that stated that 
physician groups had significantly more awareness about HPV and the HPV vaccine than non- 
physician staff members.25 Another study stated that both nurses and doctors had a positive attitude 
towards HPV cervical cancer and HPV vaccination.26 
The implication of such findings is that more emphasis should be placed on educating the primary 
health care workers in the lower ranks to ensure that their knowledge of HPV and HPV vaccination 
is extensive and up to date. This is highly significant as it would mean that health care workers are 
well skilled and motivated to introduce the HPV vaccine to patients who require it.  
5.6  Limitations of the study 
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A limitation of the study is the fact that self-reporting questionnaires were used to collect data for 
the study, hence there was no way to tell how truthful the respondents were being when answering 
some of the questions that were personal in nature. This could have led to possible information 
bias. Some healthcare workers went home with the questionnaires before submission; it is a 
possibility that they might have consulted books or other resources before answering the questions.  
 
The majority of participants in the study were nurses. Doctors and clinical associates were in the 
minority (8%) hence, it would be difficult to make sweeping conclusions and comparisms between 
the different health care worker categories.  
 
Due to the fact that the questionnaire used for the cervical cancer section was initially designed for 
students, part of the questionnaire asking for their sources of information about cervical cancer 
included options such as leaflets, television, friends and family. These are not conventional sources 
of information for a specialized group such as health care workers hence options such as journals, 
continuous professional development sessions and trainings were not available as sources of 
information in the questionnaire hence a limitation to the study. 
 
HIV has been noted to be closely linked to the development of HPV and cervical cancer, however 
the questionnaire used for this study did not adequately test the participants about this relationship. 
This is a limitation in this study. 
 
 
5.7    Conclusion 
 
Studies have been done assessing knowledge of cervical cancer, HPV and HPV vaccination, 
however, a paucity of these studies was noted among rural based South African primary health 
care workers. A majority of the study participants had adequate knowledge on HPV vaccine, but 
lacked knowledge on cervical cancer and HPV. 
This was an alarming finding as it was expected that primary health care workers should be 
extensively knowledgeable about cervical cancer since they are in a position of giving health 
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information to patients. Cervical cancer is the second most common cancer among women in South 
Africa, hence this knowledge deficit among primary health care workers constitutes a grave 
concern.  
Though this study has shown that doctors have more knowledge than other health care categories, 
the majority of participants were nurses. Nurses are the pillars of primary health care in South 
Africa, hence their knowledge of cervical cancer, HPV and HPV vaccinations should be 
sufficiently adequate to reduce the burden of cervical cancer.  
The Pap smear is a significant tool in the arsenal for the fight against cervical cancer, especially in 
developing countries. It plays a prominent part in the national guidelines for cervical cancer 
screening and is of high importance if health care workers are well trained and appropriately 
knowledgeable on it. This study has highlighted the finding that health care workers are not 
knowledgeable about the intervals and the correct age for a Pap smear test. 
A low proportion of the respondents in the study had obtained their information about cervical 
cancer from health care professionals. This is particularly worrying as the information received 
from this other source may not be factually correct. It could also indicate that patients attending 
health care facilities might not be getting appropriate health education messages from these 
facilities. This is an area that needs to be scrutinized and improved drastically. 
Knowledge of HPV amongst the primary health care workers was found to be inadequate, and 
suggested that there is low awareness of the link between HPV and cervical cancer.  
Surprisingly enough, a majority of the primary health care workers had adequate knowledge about 
the HPV vaccine. This could be due to campaigns and the recent training regarding HPV 
vaccination. 
Primary health care workers are the bedrock of the health care system. Our study shows that  gaps 
still exist in the knowledge levels of health care workers, who are in the forefront of the fight 
against cervical cancer. Educating primary health care workers through various means including 
continuous professional development particularly for health care workers in remote areas could 
help correct this knowledge deficit gap.  
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CHAPTER SIX      RECOMMENDATIONS 
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 Workshops and training on cervical cancer, HPV and HPV vaccination should be given to 
all primary health care workers on a regular basis.  
 National guidelines on cervical cancer and HPV in the form of colourful posters should be 
placed in strategic areas in all primary health care facilities. 
  Health education on cervical cancer, HPV and HPV vaccination should be offered by 
primary health care workers to their clients on a regular basis. 
 Family physicians should take the lead in educating / training primary health care workers 
at all local facilities on how to do Pap smear tests. 
 Family physicians should also do regular audits of Pap smear techniques and results. 
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APPENDIX A: QUESTIONNAIRRE  
QUESTIONNAIRE STUDY ABOUT KNOWLEDGE OF CERVICAL CANCER AMONG 
PRIMARY HEALTH CARE WORKERS IN THE MAMUSA AND NALEDI SUB –
DISTRICTS, NORTH WEST PROVINCE 
 
Instructions 
This questionnaire attempts to assess your knowledge about cervical cancer, HPV and HPV 
vaccination. Please answer all the questions. If you are unsure about which response to give to a 
question, please choose the ONE that appears most appropriate.  Thank you for your time. 
 1        SOCIO-DEMOGRAPHIC CHARACTERISTICS 
 
1)  Age………………………………………………………………………............... 
2)  Place of work……………………………………………………………………… 
3)  Gender: Male    ☐        Female   ☐ 
4)  Race ……………………………………………………………………………….  
5) Health care worker category? (Please mark the correct option) 
☐Doctor   ☐ Clinical associate    ☐ Professional nurse   ☐ Enrolled nurse    ☐ 
Enrolled nursing assistant  
6)  Highest level of education………………………………………………………… 
 
II      GENERAL KNOWLEDGE ABOUT CERVICAL CANCER 
 
 
 (Please mark with the one option that you feel best answers the question)   
 
 
1. Have you heard about cervical cancer?      
Yes      ☐    No        ☐   I don’t know ☐   
X 
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2. Can cervical cancer be a terminal illness (can you die from cervical cancer)? 
Yes    ☐      No     ☐      I don’t know ☐   
3. Can cervical cancer be associated with an infection? 
Yes    ☐      No     ☐      I don’t know ☐   
4. Is there an effective method that significantly reduces the risk of this disease? 
Yes    ☐    No     ☐    I don’t know ☐ 
5. Have you ever had direct contact with the disease (e.g., has any of your a relative or 
friends suffered from it)? 
Yes    ☐    No     ☐    I don’t know ☐ 
6. Do you think this disease could affect you in future?  
Yes    ☐    No     ☐    I don’t know ☐ 
III   RELATIONSHIP BETWEEN ESTIMATED RISK FACTORS AND THE 
OCCURRENCE   OF CERVICAL CANCER 
 
With 0 indicating no relationship and 5 indicating a very strong relationship, kindly choose 
a number that you think best denotes the strength of the relationship between the listed 
risk factors and the occurrence of cervical cancer 
 
 0 1 2 3 4 5 
Young age        
Genetic factors        
Human papilloma virus        
Human immunodeficiency 
virus (HIV) 
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Multiple sexual partners        
Early sexual initiation/debut       
History of sexually transmitted 
diseases 
      
Alcohol abuse        
Smoking       
Miscarriages and abortion       
A large number of 
pregnancies/Multiparity 
      
Early menarche        
Use of condoms        
Hormonal contraception       
Breastfeeding        
Use of psychoactive drugs       
Use of public swimming pool       
 
 
IV  KNOWLEDGE ABOUT PRIMARY PREVENTION OF CERVICAL CANCER 
 
 
A. Lifestyle 
Do you think that the following factors can reduce the risk of developing cervical cancer? 
(Please cross the one option that best responds to the question.) 
 
a) A diet rich in anti-oxidants  
Yes ☐        No ☐     I don’t know ☐ 
b) Regular physical exercise 
Yes ☐       No ☐      I don’t know ☐ 
c) Use of vitamin supplements 
Yes ☐     No ☐          I don’t know☐ 
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d) Proper long and relaxing sleep 
Yes ☐      No ☐          I don’t know ☐ 
e) Avoiding high processed food 
Yes ☐        No ☐            I don’t know ☐ 
f) Avoiding genetically modified food 
Yes ☐       No ☐          I don’t know ☐ 
g) Weight loss 
Yes ☐       No ☐           I don’t know ☐  
h) Restraint  from casual sex  
Yes ☐       No ☐       I don’t know ☐   
B. Vaccine  
a)     Have you heard about the vaccine against cervical cancer?  
          Yes ☐    No ☐   I don’t know ☐ 
b)     If such a vaccine exists, is it available in South Africa?  
        Yes ☐    No ☐   I don’t know ☐ 
c)     Is it free of charge? 
        Yes ☐    No ☐   I don’t know ☐ 
e)     Does it guarantee 100% protection from cervical cancer? 
        Yes ☐    No ☐   I don’t know ☐ 
f)     Do you know where you can get vaccinated? 
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       Yes ☐    No ☐   I don’t know ☐ 
g)     Have you ever been vaccinated? 
      Yes ☐    No ☐   I don’t know ☐ 
C. What is the best year to get vaccinated? 
       8 years ☐      9-13 years ☐      14-18years☐ 19-25years ☐ > 25 years ☐ 
 
V KNOWLEDGE ABOUT SECONDARY PREVENTION 
 
The following are the symptoms that may be associated with presence of cancer of the cervix. 
(Please cross with an X the one option that best responds to the question).  
a. Lack of symptoms from the genital areas     
Yes ☐   No ☐    I don’t know ☐   
b. Painful menstruation                                     
Yes ☐      No ☐    I don’t know ☐  
c. Intensive periods or bleeding between periods   
Yes ☐   No ☐    I don’t know ☐ 
d. Irregular menstruation or lack of menstruation  
Yes ☐    No ☐   I don’t know ☐ 
e. Smelly vaginal discharge                
Yes ☐    No    ☐ I don’t know ☐ 
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f. Itchy rash in the genital area           
Yes ☐     No ☐    I don’t know ☐ 
g. Bleeding after intercourse              
Yes ☐    No   ☐   I don’t know ☐  
h. High fever                                        
  Yes ☐    No ☐   I don’t know ☐ 
 
             VI   CYTOLOGICAL EXAMINATION 
 
 (Please mark the one option that best responds to the question). 
 
a. Have you heard of the Pap smear?   
Yes ☐   No ☐ I don’t know ☐ 
 
b. Is it a test that gives you 100% chance of early diagnosis of cervical cancer?  
Yes ☐   No ☐   I don’t know ☐  
 
c. Is the test painful?      
Yes ☐      No ☐ I don’t know ☐ 
 
d. Is it a time-consuming test?   
Yes ☐    No ☐     I don’t know ☐  
 
e. In South Africa is it possible to be tested free of charge?    
Yes ☐      No ☐     I don’t know ☐ 
 
f. Does doing the test only once eliminate the lifetime risk of cervical cancer? 
Yes ☐    No☐    I don’t know ☐ 
 
g. Can the test cause serious complications? 
Yes ☐   No☐    I don’t know ☐ 
X 
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h. Is it possible for the Pap smear to increase your chances of getting cervical cancer in the 
future?  
Yes ☐   No ☐   I don’t know☐  
 
i. How often should the Pap smear test be done?   
Every year    ☐      Every 3 years ☐    Every 5 years ☐  
Every 10years ☐        Only once ☐ 
 
j. At what age (year) can women in South-Africa undergo cytological examination free of 
charge? 
              17-25 years ☐       26-59☐years       > 60 years☐     any age ☐ 
 
k. How long after sexual initiation/debut should women undergo the test? 
              < 1year   ☐       1-3years ☐        4-6years ☐ 
 
VII    What is the source of your information about cervical cancer?   
 
  Internet ☐     Television ☐    Newspapers ☐ Doctors☐   Leaflets  ☐ 
School ☐ Family ☐   Other (please specify) __________________________________  
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 VIII KNOWLEDGE OF HUMAN PAPILLOMA VIRUS (HPV) 
  
 (Please cross with an                                the correct answer) 
HPV is very rare                                       True            False 
HPV has visible signs or symptoms         True            False 
HPV can cause cervical cancer True False 
HPV can be passed on by genital skin-to-skin contact           True False 
There are many types of HPV                True False 
HPV can cause HIV/AIDS                     True False 
HPV can be passed on during sexual intercourse            True False 
HPV can cause genital warts              True False 
Men cannot get HPV                          True False 
Using condoms reduces the risk of getting HPV           True False 
HPV can be cured with antibiotics             True False 
Having many sexual partners increases the risk of getting HPV         True False 
HPV usually doesn’t need any treatment        True False 
Most sexually active people will get HPV at some point in their lives        True False 
A person could have HPV for many years without knowing it      True False 
Having sex at an early age increases the risk of getting HPV        True False 
An HPV test can tell how long you have had an HPV infection        True False 
If a woman tests positive for HPV she will definitely get cervical cancer        True False 
An HPV test can be done at the same time as a [Pap test/Smear test/Pap 
smear test]                   
True False 
HPV testing is used to indicate if the HPV vaccine is needed        True False 
When you have an HPV test, you get the results the same day       True False 
QUESTIONNAIRE ABOUT KNOWLEDGE OF HUMAN PAPILLOMA VIRUS AND 
HPV VACCINATION AMONG PRIMARY HEALTH CARE WORKERS IN THE 
MAMUSA AND NALEDI DISTRICTS, NORTH WEST PROVINCE 
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If an HPV test shows that a woman does not have HPV, her risk of 
cervical cancer is low               
True False 
 
       IX  KNOWLEDGE ABOUT HPV VACCINATION 
 
 Please cross with an                                             the correct answer 
HPV vaccines require two doses True False 
The HPV vaccine offers protection against all sexually transmitted 
infections 
True False 
The HPV vaccines are most effective if given to people who have never 
had sex 
True False 
Someone who has had HPV vaccine cannot develop cervical cancer        True False 
The HPV vaccine offer protection against most cervical cancers      True False 
One of the HPV vaccines offers protection against genital warts         True False 
Girls who have had HPV vaccine do not need a [Pap test/Smear test/Pap 
smear test] when they are older             
True False 
X 
   
APPENDIX B:  PARTICIPANTS INFORMATION SHEET 
 
PARTICIPANT’S INFORMATION, 
Good day health care provider, 
I am Dr Ajayi Adekunle, a third year registrar in family medicine at Witwatersrand 
University and allocated at Dr Ruth Mompati District North West Province. I am conducting 
a research titled “Knowledge of Cervical cancer, Human papilloma virus and HPV 
vaccination among primary health care workers in the Mamusa and Naledi sub-district. 
North-West province”.  
This project is aimed at knowing the level of knowledge of our primary health care workers 
about pertinent issues regarding cervical cancer, HPV and HPV vaccination.  
Your personal information would not be divulged to anyone and nobody would have access 
to such information except for the researcher. 
The problems identified in this observation will be addressed, changes decided and 
implemented. The study would be conducted through the use of self-administered 
questionnaire .The findings and recommendations of the study will be reported to the staff 
working in the clinic/hospital and the authorities of the clinic/hospital. This would be done 
with the aim of improving the delivery of care to our patients. 
The results may be published in the peer-reviewed journal for academic purpose. In, both 
cases, confidentiality of your personal details will be strictly observed and protected. 
Thank you. 
Yours sincerely 
Ajayi A.O 
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